JR

Jukka Rissanen

CEO

Pharmatest Services

Turku


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Pharmatest Services
Industry
research
Employees
19.0
Seniority
C suite

Technologies

Outlook Microsoft Office 365 Google Font API reCAPTCHA WordPress.org DoubleClick Google Dynamic Remarketing Google Analytics Mobile Friendly Google Tag Manager DoubleClick Conversion Remote

Keywords

preclinical research drug discovery drug development osteoporosis cancer osteoarthritis hormonal action bone analysis model development assay development efficacy testing safety testing radiotherapy skeletal disease models oncology cro clinical biomarker services pain assesment metastasis models bone metastasis in vitro assays in vivo models preclinical efficacy rare bone disease osteogenesis imperfecta ex vivo analyses biotechnology research preclinical cro oncology models humanized mouse models cancer research biomarker services cadaver assays glucocorticoid-induced osteoporosis breast cancer models prostate cancer in vivo models radiopharmaceutical testing pain assessment multiple myeloma pancreatic cancer study ovarian cancer research clinical trial models osteoclast assays osteoblast assays bone safety testing hormonal action models chondrogenic differentiation immuno-oncology research syngeneic cancer models cancer metastasis research qualification studies glp compliance bone analysis services ex vivo models statistical analysis co-development licensing specialized research services biological markers scientific expertise clinical predictivity collaboration network histomorphometry state-of-the-art facilities customized research solutions disease model validation experiential testing drug candidate efficacy targeted radionuclide therapy fast-track approaches new preclinical models disease model development

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans